ESC 365 - Cardiovascular outcomes in women with the highest classification of maternal cardiovascular risk in pregnancy

Back

ESC Premium Access

Cardiovascular outcomes in women with the highest classification of maternal cardiovascular risk in pregnancy

Session: Cardiovascular Disease in Special Populations ePosters

Topic: Pregnancy and Cardiovascular Disease

Speaker: Doctor H. Nashat (London, GB)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Hebah Nashat

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

187 more presentations in this session

The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

Speaker: Professor J. McMurray (Glasgow, GB)

Access

Abstract

Slides

CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation

Speaker: Doctor C. Su (Taichung, TW)

Access

Abstract

Slides

Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study

Speaker: Doctor T. Rhee (Seoul, KR)

Access

Abstract

Slides

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

Speaker: Professor W. Shimizu (Tokyo, JP)

Access

Abstract

Slides

The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.

Speaker: Doctor S. Alampoondi Venkataramanan (Worcester, US)

Access

Abstract

Slides

Access the full session

Cardiovascular Disease in Special Populations ePosters

Speakers: Doctor H. Nashat, Professor J. McMurray, Doctor C. Su, Doctor T. Rhee, Professor W. Shimizu...

Access

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Applying the ESC 2016, the H2FPEF, and the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population - a comparative approach

28 August 2021

ESC Premium Access

Pregnancy and pulmonary hypertension.

27 August 2021

ESC Premium Access

Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints

27 August 2021

Cardiovascular outcomes in women with the highest classification of maternal cardiovascular risk in pregnancy

About the speaker

Doctor Hebah Nashat

187 more presentations in this session

The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation

Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.

Access the full session

Cardiovascular Disease in Special Populations ePosters

About the event

ESC Congress 2021 - The Digital Experience

Related content

Applying the ESC 2016, the H2FPEF, and the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population - a comparative approach

Pregnancy and pulmonary hypertension.

Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints

ESC 365 is supported by